COO (The Cooper) Beginning Cash Position: $125 Mil (As of Apr. 2026)


COO The Cooper Companies Inc COO
84 GF Score
Price $71.89
GF Value $101.09
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is The Cooper Beginning Cash Position?

The Cooper COO -0.99% 84 Beginning Cash Position is $125 Mil as of Apr. 2026. GuruFocus rates COO with a GF Score™ of 84/100 and a GF Value™ of $101.09 (Modestly Undervalued). The stock has 3 warning signs investors should review.

The Cooper's Beginning Cash Position for the quarter that ended in Apr. 2026 was $125 Mil.

The Cooper's quarterly Beginning Cash Position declined from Oct. 2025 ($125 Mil) to Jan. 2026 ($111 Mil) but then increased from Jan. 2026 ($111 Mil) to Apr. 2026 ($125 Mil).

The Cooper's annual Beginning Cash Position declined from Oct. 2023 ($139 Mil) to Oct. 2024 ($121 Mil) and declined from Oct. 2024 ($121 Mil) to Oct. 2025 ($108 Mil).

The Cooper Beginning Cash Position Related Terms

The Cooper Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for The Cooper's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Cooper Beginning Cash Position Chart

The Cooper Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 116.80 96.60 138.60 120.90 107.70

The Cooper Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 101.00 116.20 124.90 110.60 125.00
COO
84GF Score
The Cooper Companies Inc COO
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Cooper Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $125 Mil mean?
The Cooper (COO) has a Beginning Cash Position of $125 Mil as of Apr. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on The Cooper and its competitors.
Is The Cooper's Beginning Cash Position too high?
The Cooper's current Beginning Cash Position is $125 Mil. Overall, The Cooper has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cooper's Beginning Cash Position compare to SOLV and ALGN?
The Cooper's Beginning Cash Position of $125 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on The Cooper and its competitors. The Cooper's current Beginning Cash Position is $125 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cooper stock overvalued right now?
Based on GuruFocus' analysis, The Cooper (COO) is currently considered Modestly Undervalued. The stock's GF Value™ is $101.09, compared to a current price of $71.89 — trading 28.9% below its estimated fair value. The current Beginning Cash Position is $125 Mil. The Cooper's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For The Cooper (COO), the current Beginning Cash Position is $125 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Cooper (COO) Overvalued in 2026?

Based on GuruFocus' analysis, The Cooper stock appears to be undervalued. The current stock price of $71.89 is trading 28.9% below its estimated GF Value™ of $101.09. GuruFocus considers The Cooper to be Modestly Undervalued.

Key valuation signals for COO:

  • Beginning Cash Position: $125 Mil
  • GF Value™: $101.09 vs. price of $71.89 (28.9% below fair value)
  • GF Score™: 84/100 with 3 warning signs

No single metric tells the full story. See the COO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Cooper Business Description

Address 6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
84GF Score

Get the complete analysis for COO

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$71.89
Price
$101.09
GF Value